Eli Lilly becomes first drugmaker to have a GLP-1 weight loss pill approved in China
By Andrew Silver
SHANGHAI, Nov 12 (Reuters) - Eli Lilly on Thursday became the first company to have a GLP-1 weight-loss pill approved in China, gaining a leg up on Danish rival Novo Nordisk in the world's second-largest pharmaceutical market.
The pill, orforglipron, will compete for... Read More.


